DAFTAR PUSTAKA 1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378(9785):31–40.
2. French LA, Boen JR, Martinez AM et al. Population Based Study Impaired Glucose Tolerance and Type 2 diabetes in Wadena, minesota. Diabetes; 1990.
3. Wild,S et al. Global Prevalence of diabetes. Estimates for Year 2000 and Projections for 2030. Diabetes Care 2004 ;27 (5): 1047-1053.
4. Soegondo S, purnamasari D Waspadji S, saksono D. Prevalensi of diabetes mellitus in Jakarta. The Jakarta primary non communicable disease risk factors surveillance .2006.
5. Anonim. Buku Profil Kesehatan Provinsi JawaTengah Tahun 2012. Dinas Kesehatan Jawa Tengah : Semarang. 2012.
6. Anonim. Data Kementrian Kesehatan RI Tahun 2010. Jakarta.
7. Ram vinod mahato, prajwal Gyawali, Pramod Psd. Assosiated between glycemic control and serum lipid profile in type 2 diabetes patient: HbA1c as dual biomarker. Biomedical research 2011;22(3) :375-380
91
http://digilib.unimus.ac.id
8. Karel Pandelaki. Diabetic dyslipidemia management. The first east Indonesia Endo-metabolic update. PERKENI cabang makasar ; 2006.p. 24-31
9. Khan, HA. Clinical significance of HbA1c as marker of circulating lipids in male and female type 2 diabetic patient. Acta diabetol ; 2007 ;(44):193200
10. PERKENI. Pengelolaan dan Pencegahan Diabetes Melitus Tipe II di Indonesia 2011. Jakarta : PERKENI; 2011.
11. American Diabetes Assosiation. Standart of medical care in diabetes. Diabetes care;2004.p. S15-S35.
12. Pujari, S.Subhash. HbA1c as marker of dyslipidemia in type 2 diabetes mellitus patients.Sch.J.App.Med.Sci, 2013.1(6) : 728-731.
13. Shoback, edited by David G. Gardner, Dolores . Greenspan's basic & clinical endocrinology (9th ed.). New York: McGraw-Hill Medical. ISBN 0-07-162243-8; 2004.
14. Loei,Glorya Stevani Cicilia, Pandelaki,Karel, Mandang,Veny. Hubungan kadar HbA1c dengan profil lipid pada pasien diabetes melitus tipe II di poliklinik endokrin dan metabolic RSUP Prof.DR.D.Kandau Manado.2013
15. Al-alwi, Amur Sulaiman. Serum lipid profile and glycated hemoglobin status in Omani patients with type 2 diabetes mellitus attending a primary care polyclinic. Biomed Res India. 2014;25(2) :161-166.
92
http://digilib.unimus.ac.id
16. Al- Quran Surah Taha ayat 81.
17. Prabhavathi,
Kirthana
Kunikullaya,
Jaisri
Gotoru.
Gylcosylated
heamoglobin (HbA1c) a marker of circulating lipid in tupe 2 diabetic patients. Journal of Clinical and Diagnostic Research. 2014 Feb, Vol -8 (2) : 20-23.
18. Charitha, B. Arul Senghor, Meera Shivashekar. HbA1c as dual marker in control glicemic status and diabetic dyslipidemia. International Journal of Pharmaceutical and Clinical Research 2013 ;5(3) : 111-113.
19. Shoback, edited by David G. Gardner, Dolores (2011).Greenspan's basic & clinical endocrinology (9th ed.). New York: McGraw-Hill Medical. pp. Chapter 17. ISBN 0-07-162243-8.
20. Kumar, Vinay; Fausto, Nelson; Abbas, Abul K.; Cotran, Ramzi S. ; Robbins, Stanley L. Robbins and Cotran Pathologic Basis of Disease (7th ed.). Philadelphia, Pa.: Saunders. pp. 1194–1195. ISBN 0-7216-0187-1 ; 2004.
21. Anonim A. 2010. Diabetes Mellitus type II. American Diebetes Assosiation. America.
22. Tedjapranata, M., Diabetes Di Usia Lanjut Memang Berbahaya, Namun Dapat Dijinakkan[serial
online]
[
cited
2014
June
20];
Available
from:http://www.gbimawarsaron.com/kesehatan/27-diabetes-mellitus.html
93
http://digilib.unimus.ac.id
23. Powers, A.C. Diabetes mellitus. In D.L.Kasper, E.Braunwald, A.S.Fauci, S.L.Hauser, D.L.Longo, J.L.Jameson: Harrison’s principles of internal medicine. vol 4. 16th ed. USA: McGraw-Hill Companies, Inc. Hal. 2152. 2005.
24. Guyton, Arthur, Hall, John E. Buku Ajar Fisiologi Kedokteran Edisi 11. Jakarta: EGC; 2006.
25. American Diabetic Assosiation: standarts of medical care in diabetes 2008 (position statement). Diabetes Care 2008 ;31 (Suppl.1):S12-54
26. Report Of The Expert Committee On The Diagnosis And Classification Of American Diabetes Mellitus. The Expert Committee On The Diagnosis And Classification Of The Diabetes Mellitus. Diabetes Care. 2012; 22 (Suppl. 1) : S5 –S20.
27. Hardjono. Tes Diabetes Melitus. Dalam Hardjono dkk. Interpretasi Hasil Diagnostik Tes Laboratorium Diagnostik. Cetakan 3. Lembaga Pendidikan Universitas Hasanudin. Makasar. 2006. p. 201-06.
28. Rachmawati, A.M., Bahrun, U., Rusli, B., Hardjoeno. Tes Diabetes Melitus. Dalam Hardjono dkk. Interpretasi Hasil Diagnostik Tes Laboratorium Diagnostik. Cetakan 3. Lembaga Pendidikan Universitas Hasanudin. Makasar. 2007. p. 167-82.
29. Soewondo P. Pemantauan Pengendalian Diabetes Mellitus. Dalam Soegondo S dkk (eds), Penatalaksanaan Diabetes Mellitus Terpadu. Penerbit FKUI. Jakarta. 2005.
94
http://digilib.unimus.ac.id
30. Pagana, Desta Kathlen, Pagana,Thymothy. Mosby’s Diagnostic and Laboratorium Test Reference 11th. Elsevier ; 2012.
31. Plaza, M. N., C. Santana , Y.M. Font, A. M.Mayor, and L. M. Vila. Assosiasion Hand or Knee Ostheoarthritis With Diabetes Mellitus in a population of Hispanic Puerto Rico. 2013.
32. Adnan, M. Reumatik non Artikuler. Simposium RNA. Semarang. Oktober 1987:8-14
33. Price, A. Sylvia and L.M. Wilson. Patofisiologi Konsep Dasar Klinik dan Pneyakit. EGC; 2006.
34. Soegondo, Sidartawan.Diabetes Melitus sebagai faktor resiko utama penyakit kardiovaskuler.Jakarta: Pendidikan Kedokteran Berkelanjutan Ikatan Dokter Indonesia:2006.
35. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ Translating
the
A1C
values.".Diabetes
assay
into
estimated
Care 31 (8):
average
glucose
1473–8. doi:10.2337/dc08-
0545. PMC 2742903.PMID 18540046; 2006..
36. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus [serial online] 2011 [ cited 2014 june 20]; available from : www.who.int/diabetes/publications/report-hba1c_2011.pdf.
37. Standardisation of the reference method for the measurement of HbA1c to improve diabetes care" (PDF). The Association for Clinical Biochemistry and Diabetss UK. April 2008. Retrieved 2009-07-02.
95
http://digilib.unimus.ac.id
38. Mayes,PA. Hemoglobin Terglikosilasi Harper’s Biokimia. Edisi 2007. Jakarta: EGC; 2007.
39. Kee, JL. Pedoman Pemeriksaan Laboratorium dan diagnostic. Jakarta :EGC; 2003.
40. Soewondo P. Pemantauan Pengendalian Diabetes Mellitus. Dalam Soegondo S dkk (eds), Penatalaksanaan Diabetes Mellitus Terpadu. Penerbit FKUI. Jakarta. 2005.
41. Shima K, Chujo K, Yamada M, Komatsu M, Noma Y, Mizuguchi T. Lower value of glycated haemoglobin relative to glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis. Ann Clin Biochem 2012;49:68–74
42. Benuck,I. Gidding SS, Donovan M. Year to year variability pf cholesterol level in pediatric practice. Arch Pediatric AdolescMed 1995:149:2292-6
43. Sherwood, Lauralee. Fisiologi Manusia dari sel ke system Edisi 6. Jakarta; EGC;2011.
44. Mogensen, CE and Belfore , F. New Consepts in diabetes and its treatment. 2000.Karger
45. Adam, JMF. Dislipidemia. Dalam : Sudoyono, W.A. Setyohadi, B.Alwi, I. Buku Ajar Ilmu Penyakit Dalam Jilid III Edisi 4. Jakarta : Pusat Penerbitan Ilmu Penyakit DalamFKUI, 1926-1932. 2005.
96
http://digilib.unimus.ac.id
46. Soehartono,
Toni.
Dislipidemia
pada
Diabetes
Melitus.
Dalam:
Djokomoeljanto. Naskah Lengkap ditinjau dari Berbagai Aspek Penyakit Dalam. Semarang: Badan Penerbit Universitas Diponegoro;2007.
47. Jawaharlal W.B. Senaratne and Green FR. Pathobiology of atherosclerosis. In Peter J. Morris,William C. Wood Oxford eds. Textbook of Surgery, 2nd edition. US: Oxford press; 2000: Vol. 3
48. Frank MS, McPerson R, Brian W, Effect of post menopausal estrogen replacement on plasma Lp(a) Lipoprotein Concentrations, Arch Intern Med, 1994, 154-,1106-10.
49. Ricart, W. & Real, J.M. F.. No Decrase in Free IGF-I with Increasing Insulin in Obesity-Related Insulin Resistance. Obesity Research, 9, 631636, 2001.
50. Lemeshow,S; DW Hosmer Jr. Adequacy of Sample Size in Health Studies. WHO. John Wiley and Sons Ltd. England. 1993.
51. Sastroasmoro, Sudigdo. Pengukuran dalam Penelitian. In: Sastroasmoro S dan Ismael S. Dasar dasar Metodologi Penelitian Klinis Edisi Ketiga. Jakarta : Seagung Seto; 2007.
52. Bahri,A. Dislipidemia Sebagai Faktor Resiko Penyakit Jantung Koroner. EUSU Respirator. Fakultas Kedokteran Univeristas Sumatra Utara;2004.
53. Tumbeleka AR, Riono P. Pemilihan Uji Hipotesis In: In: Sastroasmoro S dan Ismael S. Dasar dasar Metodologi Penelitian Klinis Edisi Ketiga. Jakarta : Seagung Seto;2007.
97
http://digilib.unimus.ac.id
54. Data Rekam Medis Rumah Sakit Umum Daerah Dr. Adhiatma Semarang Poli Penyakit Dalam Periode 1 Januari 2013 – 31 Desember 2013.
55. Effendi, Rustam. Gambaran distribusi penderita diabetes melitus rawat jalan di badan RSUD Manna Bengkulu Selatan 1999-2001; Universitas Sumatra Utara. 2012.
56. Josten, S, Mutmainnah, Hardjoeno. Profil lipid penderita diabetes melitus tipe 2.Indonesian Journal of clinical pathology dan medical laboratory, Vol 13, No.1 Nov 2006 ;20-22.
57. Ramona, gligor, dkk. Relationship between glycosylated hemoglobin and lipid metabolism in patients with type 2 diabetes. Journal studia universitatis “Vashile Gordis” Vol 21, Issue 2, 2011, pp. 313-318.
58. Shivanand, K.G. Lipid profile and its complication in diabetes melitus. IJBAR. 2012. Diperoleh ari : http://ijbar.ssjournal.com. Diakses 1 november 2014.
59. Adm. Kadar HbA1c mencerminkan kadar profil lipid. Sept. 2011. Diperoleh dari : http:// www. Pjnhk.go.id/content/view. Diakses 1 november 2014.
98
http://digilib.unimus.ac.id
